Patent details
EP3554540 Title: TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH AN IL-12/IL-23 INHIBITOR RELEASED USING AN INGESTIBLE DEVICE
Basic Information
- Publication number:
- EP3554540
- PCT Application Number:
- US2017066474
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP178266417
- PCT Publication Number:
- WO2018112232
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH AN IL-12/IL-23 INHIBITOR RELEASED USING AN INGESTIBLE DEVICE
- French Title of Invention:
- TRAITEMENT D'UNE MALADIE DU TRACTUS GASTRO-INTESTINAL AVEC UN INHIBITEUR DES INTERLEUKINES IL-12/IL-23 LIBÉRÉ À L'AIDE D'UN DISPOSITIF INGÉRABLE
- German Title of Invention:
- BEHANDLUNG VON ERKRANKUNGEN DES GASTROINTESTINALTRAKTES MIT EINEM IL-12/IL-23 INHIBITOR MIT FREISETZUNG ANHAND EINER ESSBAREN VORRICHTUNG
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 08/08/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 11/08/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 02/08/2023
- Unitary Effect Registration Date:
- 11/08/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 14/12/2017
- Grant date:
- 02/08/2023
- EP Publication Date:
- 23/10/2019
- PCT Publication Date:
- 21/06/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 02/08/2023
- EP B1 Publication Date:
- 02/08/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 14/12/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 26/07/2023
- Name:
- Biora Therapeutics, Inc.
- Address:
- 4330 La Jolla Village Drive, Suite 200, San Diego, CA 92122, United States (US)
Inventor
1
- Name:
- SINGH, Sharat
- Address:
- United States (US)
2
- Name:
- STYLLI, Harry
- Address:
- United States (US)
3
- Name:
- JONES, Mitchell Lawrence
- Address:
- United States (US)
4
- Name:
- WAHL, Christopher Loren
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201662434348 P
- Priority Date:
- 14/12/2016
- Priority Country:
- United States (US)
2
- Priority Number:
- 201762478744 P
- Priority Date:
- 30/03/2017
- Priority Country:
- United States (US)
3
- Priority Number:
- 201762545188 P
- Priority Date:
- 14/08/2017
- Priority Country:
- United States (US)
4
- Priority Number:
- 201762583797 P
- Priority Date:
- 09/11/2017
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 39/395; A61K 38/13; A61K 9/00; C07K 16/24; C12N 15/113; C07K 16/28; A61B 10/00; A61P 1/00; A61P 1/04; A61P 29/00; A61P 35/00; A61P 37/04; A61P 37/06; A61P 43/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202331
- Publication date:
- 02/08/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202337
- Publication date:
- 13/09/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202337
- Publication date:
- 13/09/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|